Most of the cancer news this week happened at the massive ASCO meeting in Chicago. But not all, as we’ll see in a moment.
Also this week, Biogen and Eisai reported good news about an Alzheimer’s drug, but with plenty of... Read more »
Momentum has been building for New York biotech for several years now. But the life sciences sector still remains more of an afterthought in a city better known for its financial might. While several ingredients are already in place in New... Read more »
Biogen has yet to make the big, transformative buyout Wall Street investors have hoped for. But it continues to place small bets to build up its neurology pipeline. The latest is a deal to pick up a compound now in mid-stage... Read more »
Data released Wednesday afternoon looks to have eased a potential threat to Vertex Pharmaceuticals’ burgeoning cystic fibrosis franchise, though news from another challenger looms later this month.
Proteostasis Therapeutics (NASDAQ: PTI) released data from a 49-patient Phase 1 study testing... Read more »
Despite all the hype and business investment, drones are mostly flown by hobbyists and the military these days, says Ken Stewart. But if he and other drone supporters have their way, the sky will eventually be dotted with unmanned aircraft delivering... Read more »
Athenahealth announced Wednesday that Jonathan Bush, its co-founder and chief executive, is stepping down, and the healthcare IT company will explore “strategic alternatives” that could include a sale.
The news sent Athenahealth’s stock price up about 4 percent Wednesday morning, to... Read more »
Nimbus Therapeutics’ drugs have already found new homes with larger companies that aim to develop them into potential treatments for autoimmune and liver diseases. Selling its discoveries was a goal for Nimbus from its inception. But the Cambridge, MA, biotech has... Read more »
The American Society of Clinical Oncology annual meeting, the world’s largest cancer conference, wraps up today in Chicago. Investors have dissected the data, picked winners and losers, and sent some biotech stocks soaring and others tumbling.
In the days before ASCO,... Read more »
Maxwell Health’s quest to simplify the mind-numbing tasks of buying health insurance and administering other employee benefits will now continue under the wing of one of the startup’s investors.
Boston-based Maxwell announced Monday it has been acquired by Sun Life Financial... Read more »